David Gustafsson

AstraZeneca R&D
Moelndal, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Novel histone deacetylase inhibitor, CS014, attenuates in vivo thrombosis while maintaining hemostasis.

Novel histone deacetylase inhibitor, CS014, attenuates in vivo thrombosis while maintaining hemostasis.

Journal: Journal of thrombosis and haemostasis : JTH
Published: June 04, 2025

Breathlessness dimensions should be evaluated in relation to the level of exertion: A clinical study.

Breathlessness dimensions should be evaluated in relation to the level of exertion: A clinical study.

Journal: Respiratory physiology & neurobiology
Published: October 30, 2024

UAS hydrometry: contactless river water level, bathymetry, and flow velocity - the Rӧnne river dataset.

UAS hydrometry: contactless river water level, bathymetry, and flow velocity - the Rӧnne river dataset.

Journal: Scientific data
Published: June 27, 2024

The modified Medical Research Council scale misclassifies exertional breathlessness among people referred for exercise testing.

The modified Medical Research Council scale misclassifies exertional breathlessness among people referred for exercise testing.

Journal: ERJ open research
Published: August 14, 2023

Prognosis in moderate-severe traumatic brain injury in a Swedish cohort and external validation of the IMPACT models.

Prognosis in moderate-severe traumatic brain injury in a Swedish cohort and external validation of the IMPACT models.

Journal: Acta neurochirurgica
Published: September 09, 2021

The Role of BDNF in Experimental and Clinical Traumatic Brain Injury.

The Role of BDNF in Experimental and Clinical Traumatic Brain Injury.

Journal: International journal of molecular sciences
Published: February 25, 2021

Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function.

Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function.

Journal: The Journal of biological chemistry
Published: October 04, 2019

Development of Human Target Validation Classification that Predicts Future Clinical Efficacy.

Development of Human Target Validation Classification that Predicts Future Clinical Efficacy.

Journal: The Journal of pharmacology and experimental therapeutics
Published: May 24, 2018

Plasminogen binding inhibitors demonstrate unwanted activities on GABAA and glycine receptors in human iPSC derived neurons.

Plasminogen binding inhibitors demonstrate unwanted activities on GABAA and glycine receptors in human iPSC derived neurons.

Journal: Neuroscience letters
Published: February 22, 2018

Discovery and Evaluation of Anti-Fibrinolytic Plasmin Inhibitors Derived from 5-(4-Piperidyl)isoxazol-3-ol (4-PIOL).

Discovery and Evaluation of Anti-Fibrinolytic Plasmin Inhibitors Derived from 5-(4-Piperidyl)isoxazol-3-ol (4-PIOL).

Journal: Journal of chemical information and modeling
Published: June 28, 2017

Macrocyclic Prodrugs of a Selective Nonpeptidic Direct Thrombin Inhibitor Display High Permeability, Efficient Bioconversion but Low Bioavailability.

Macrocyclic Prodrugs of a Selective Nonpeptidic Direct Thrombin Inhibitor Display High Permeability, Efficient Bioconversion but Low Bioavailability.

Journal: Journal of medicinal chemistry
Published: June 28, 2016

Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase β inhibition and aspirin in man.

Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase β inhibition and aspirin in man.

Journal: Journal of thrombosis and haemostasis : JTH
Published: May 04, 2015
Showing 1-12 of 26

Last Updated: 09/26/2026